Althea Hill Payne
Primary Care · Holmdel, NJNPI 1417429770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$768
- Novartis$494
- Lilly USA, LLC$355
- UCB, Inc.$345
- Biogen$289
- Amneal Pharmaceuticals LLC$227
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,095100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $768 |
| Novartis | 54 | $494 |
| Lilly USA, LLC | 15 | $355 |
| UCB, Inc. | 15 | $345 |
| Biogen | 10 | $289 |
| Amneal Pharmaceuticals LLC | 15 | $227 |
| Lundbeck LLC | 13 | $195 |
| Neurocrine Biosciences, Inc. | 9 | $142 |
| Eisai Inc. | 9 | $141 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $107 |
| Axsome Therapeutics, Inc. | 1 | $107 |
| Argenx US, Inc. | 6 | $100 |
| Johnson & Johnson | 5 | $90 |
| Pfizer | 5 | $80 |
| Impel Pharmaceuticals Inc. | 4 | $71 |
| Genentech USA, Inc. | 4 | $68 |
| SK Life Science, Inc. | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Acorda Therapeutics, Inc | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| GE HealthCare | 2 | $42 |
| Grifols USA, LLC | 2 | $39 |
| AstraZeneca | 2 | $32 |
| Neurelis, Inc. | 2 | $32 |
| Kyowa Kirin, Inc. | 2 | $28 |
| Mallinckrodt Hospital Products Inc. | 2 | $25 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| TG Therapeutics, Inc. | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Sanofi | 1 | $16 |
| Banner Life Sciences, LLC | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| EMD Serono, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,095 in reported general payments places this provider in the 90th percentile of 330 primary care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 21 | $32,439 |
| Nurtec OdtRimegepant Sulfate | 11 | $15,439 |
| QuliptaAtogepant | 11 | $13,524 |
| Memantine Hcl ErMemantine Hcl | 18 | $1,225 |
| Levetiracetam | 34 | $918 |
| Memantine Hcl | 19 | $375 |
| Donepezil Hcl | 37 | $349 |
| Gabapentin | 27 | $207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $768 | $45,96332 claims |
| PfizerNurtec Odt | $80 | $15,43911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 330 primary care providers in New Jersey.
Other primary care in Holmdel
- Jennifer DemberHolmdel$5K
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.